Printer Friendly

Syngenta granted fifth transgenic Bt patent - files suit against competitors.

The United States Patent and Trademark Office in Washington, DC has issued United States Patent 6,720,488. This patent is the fifth in a series of transgenic patents issued to Syngenta (Washington, DC) in the field of insect resistant corn. All five patents cover synthetic Bt genes that provide useful products to corn growers by conferring resistance to two economically important insect pests: the European corn borer and the corn rootworm.

Three of the previously issued patents are the subject of a lawsuit Syngenta filed on July 25, 2002 in Federal District Court in Wilmington, Delaware. The lawsuit charges that Monsanto, DeKalb Genetics, Pioneer Hi-Bred, Dow AgroSciences and Mycogen Seeds are infringing one or more of these patents with their YieldGard and Herculex product lines. The lawsuit is expected to go to trial in November 2004.

Syngenta has filed a new lawsuit in Federal District Court in Wilmington, Delaware seeking damages and injunctive relief against the same defendants for the infringement of the latest patent.

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2003 were approximately $6.6 billion. Syngenta employs more than 19,000 people in over 90 countries.

Syngenta

+1-202-347-8348

www.syngenta.com
COPYRIGHT 2004 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:bacillus thuringiensis; Syngenta AG
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:Apr 1, 2004
Words:221
Previous Article:Abbott and Orion expand collaboration for injectable levosimendan.
Next Article:Xanthus receives patent on lead anti-cancer compound Xanafide amonafide.
Topics:


Related Articles
Dow AgroSciences LLC.
Syngenta files suit to enforce biotechnology patents.
Syngenta and Monsanto offer farmers access to agricultural technologies.
Monsanto fles patent infringement suit against Syngenta over GA21(R) corn.
Monsanto fles patent infringement suit against Syngenta over GA21 corn.
Swiss biotech giant Syngenta has announced that its U.S. subsidiary Syngenta Seeds has filed a lawsuit against Monsanto, accusing its rival of having...
Dow Chemical Co. said it won rights to a "broad and enabling" technology for creating genetically modified crops, such as those sold by Monsanto Co.
New GM toxin looms over our food.
Syngenta rights to GA21 in corn reaffirmed by Federal Circuit.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters